| Literature DB >> 34581833 |
Marcel Coutandin1, Yama Afghanyar1, Philipp Rehbein1, Jens Dargel1, Philipp Drees2, Karl Philipp Kutzner3,4.
Abstract
BACKGROUND: Short stems have constantly gained popularity in primary total hip arthroplasty (THA) over the last decade. Although cementless short stems are not primarily designed to be used as revision implants, there may be certain indications for which downsizing the femoral component in failed conventional THA is potentially advantageous.Entities:
Keywords: De-escalation; Hip replacement; Optimys; Revision surgery; Short stem
Mesh:
Year: 2021 PMID: 34581833 PMCID: PMC8894309 DOI: 10.1007/s00132-021-04168-8
Source DB: PubMed Journal: Orthopade ISSN: 0085-4530 Impact factor: 1.087
Patient characteristics
| Year (index surgery) | Failed stem | Side | Gender | Age (years, at revision) | BMI | Paprosky | Indication | |
|---|---|---|---|---|---|---|---|---|
| Pat. 1 | 2006 | Marathon (Smith&Nephew, Watford, UK) | Left | Male | 82 | 30.5 | II | Aseptic loosening |
| Pat. 2 | 2013 | Revitan (Zimmer Biomet, Warsaw, IN, USA) | Left | Male | 65 | 38.6 | II | Implant fracture |
| Pat. 3 | 2015 | CLS Spotorno (Zimmer Biomet, Warsaw, IN, USA) | Right | Male | 63 | 25.1 | I | Aseptic loosening |
| Pat. 4 | 2016 | MEM (Zimmer Biomet, Warsaw, IN, USA) | Left | Male | 82 | 22.1 | IIIa | Periprosthetic infection |
| Pat. 5 | 2011 | Rippenschaft (Link, Hamburg, Germany) | Left | Male | 77 | 25.7 | I | Aseptic loosening |
| Pat. 6 | 2000 | ABG 2 (Stryker, Kalamazoo, MI, USA) | Left | Male | 72 | 23.3 | II | Aseptic loosening |
BMI body mass index
Fig. 1Flow diagram of the patients included in the study. HRA Hip resurfacing arthroplasty
Fig. 2The optimys short stem (With kind permission © MathysAG Bettlach, Switzerland, all rights reserved)
Clinical outcomes
| Follow-up (years) | HHS | WOMAC (In %) | EQ-5D-5L (Index) | Pain (VAS) | Satisfaction (VAS) | |
|---|---|---|---|---|---|---|
| Pat. 1 | 4.0 | 71 | 21.9 | 0.738 | 1 | 9 |
| Pat. 2 | 4.2 | 96 | 1.0 | 0.910 | 2 | 9 |
| Pat. 3 | 3.5 | 100 | 0.0 | 0.909 | 0 | 9 |
| Pat. 4 | 3.0 | 79 | 31.3 | 0.723 | 0 | 9 |
| Pat. 5 | 2.6 | 96 | 1.0 | 0.828 | 3 | 9 |
| Pat. 6 | 2.6 | 100 | 0.0 | 1.000 | 0 | 10 |
HHS Harris Hip Score, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, EQ-5D-5L health status by the EuroQol Group, VAS visual analogue scales
Fig. 3Radiographs of the hip joint of patients 1 (a–c), 2 (d–f) and 3 (g–i), a,d,g preoperatively, b,e,h postoperatively, c,f,i at last follow-up
Fig. 4Radiographs of patients 4 (a–c), 5 (d–f) and 6 (g–i), a,d,g preoperatively, b,e,h postoperatively, c,f,i at last follow-up
Overview of studies investigating primary conventional cementless stems used as a revision implant
| Study | Implant | N (hips) | Follow-up (years) | Survival (%) |
|---|---|---|---|---|
| Tauber et Kidron, 2000 [ | CLS Spotorno (Zimmer Biomet, Warsaw, IN, USA) | 24 | 4.5 | 96 |
| Kelly et al., 2006 [ | Securfit plusTM (Stryker, Kalamazoo, MI, USA) | 32 | 5 | 91 |
| Thorey et al., 2008 [ | Bicontact (BBraun Aesculap, Melsungen, Germany) | 79 | 7 | 95 |
| Salemyr et al. 2008 [ | Bi-Metric (Zimmer Biomet, Warsaw, IN, USA) | 62 | 6.1 | 93.6 |
| Pinaroli et al., 2009 [ | Corail (Depuy Synthes, Raynham, MA, USA) | 41 | 2.5 | 100 |
| Miletic et al., 2012 [ | Alloclassic (Zimmer Biomet, Warsaw, IN, USA) | 15 | 4.5 | 100 |
| Tetreault et al., 2014 [ | Various | 144 | 4 | 90.2 |
| Khanuja et al., 2014 [ | Accolade TMZF (Stryker, Kalamazoo, MI, USA) | 19 | 5 | 94.8 |
| Gastaud et al., 2016 [ | Linea (Tornier, Burscheid, Germany) | 43 | 4 | 100 |